Cargando…

Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma

Detalles Bibliográficos
Autores principales: Ray, Arghya, DU, Ting, Chauhan, Krishan, Chauhan, Dharminder, Anderson, Kenneth C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665253/
http://dx.doi.org/10.1182/blood-2022-170226
_version_ 1784831250602655744
author Ray, Arghya
DU, Ting
Chauhan, Krishan
Chauhan, Dharminder
Anderson, Kenneth C.
author_facet Ray, Arghya
DU, Ting
Chauhan, Krishan
Chauhan, Dharminder
Anderson, Kenneth C.
author_sort Ray, Arghya
collection PubMed
description
format Online
Article
Text
id pubmed-9665253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652532022-11-16 Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma Ray, Arghya DU, Ting Chauhan, Krishan Chauhan, Dharminder Anderson, Kenneth C. Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665253/ http://dx.doi.org/10.1182/blood-2022-170226 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Ray, Arghya
DU, Ting
Chauhan, Krishan
Chauhan, Dharminder
Anderson, Kenneth C.
Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title_full Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title_fullStr Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title_full_unstemmed Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title_short Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma
title_sort analysis of covid-19-associated proteins identifies tank-binding kinase 1 as an immunotherapeutic target in multiple myeloma
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665253/
http://dx.doi.org/10.1182/blood-2022-170226
work_keys_str_mv AT rayarghya analysisofcovid19associatedproteinsidentifiestankbindingkinase1asanimmunotherapeutictargetinmultiplemyeloma
AT duting analysisofcovid19associatedproteinsidentifiestankbindingkinase1asanimmunotherapeutictargetinmultiplemyeloma
AT chauhankrishan analysisofcovid19associatedproteinsidentifiestankbindingkinase1asanimmunotherapeutictargetinmultiplemyeloma
AT chauhandharminder analysisofcovid19associatedproteinsidentifiestankbindingkinase1asanimmunotherapeutictargetinmultiplemyeloma
AT andersonkennethc analysisofcovid19associatedproteinsidentifiestankbindingkinase1asanimmunotherapeutictargetinmultiplemyeloma